Related Experiment Video
Updated: Jun 1, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for
In Seok Jeong1, Woong-Han Kim2, Jong Hyun Baek3
1Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Insights
Extracorporeal membrane oxygenation (ECMO) may aid COVID-19 patients, but evidence is limited. This study reviews literature and Korean registry data to assess ECMO efficacy and provide expert recommendations for its use in treating coronavirus disease 2019.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Cardiopulmonary Support
Background:
- The COVID-19 pandemic has seen a rapid increase in cases and deaths globally.
- Extracorporeal membrane oxygenation (ECMO) is a life support technology, but its efficacy for COVID-19 remains debated among experts.
- Existing ECMO guidelines may not fully align with the Korean medical system and real-world practices.
Purpose of the Study:
- To evaluate the efficacy of ECMO in treating patients with COVID-19.
- To develop expert recommendations for ECMO application in the context of the Korean healthcare system.
- To bridge the gap between existing literature and practical clinical decision-making for ECMO in COVID-19.
Main Methods:
- Systematic literature review of studies on ECMO for COVID-19 patients.
- Analysis of data from the Korean COVID-19 ECMO registry.
- Synthesis of findings to formulate expert recommendations.
Main Results:
- Evidence on ECMO efficacy for COVID-19 is still evolving, with varied outcomes reported in the literature.
- Korean registry data provides insights into real-world application and outcomes of ECMO in COVID-19 patients.
- Specific challenges and considerations for ECMO implementation within the Korean medical system were identified.
Conclusions:
- Further research is needed to solidify the role of ECMO in COVID-19 management.
- Tailored recommendations based on national data are crucial for optimizing ECMO use in Korea.
- A balanced approach considering evidence and local context is essential for ECMO decision-making in COVID-19.
Abstract:
Since the first reported case of coronavirus disease 2019 (COVID-19) in December 2019, the numbers of confirmed cases and deaths have continued to increase exponentially despite multi-factorial efforts. Although various attempts have been made to improve the level of evidence for extracorporeal membrane oxygenation (ECMO) treatment over the past 10 years, most experts still hesitate to take an active position on whether to apply ECMO in COVID-19 patients. Several ECMO management guidelines have been published recently, but they reflect some important differences from the Korean medical system and aspects of real-world medical practice in Korea. We aimed to find evidence on the efficacy of ECMO for COVID-19 patients by reviewing the published literature and to propose expert recommendations by analyzing the Korean COVID-19 ECMO registry data.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care